Overview
The DIA China Annual Meeting as the largest interdisciplinary event in Asia that brings together a global network of life sciences professionals to foster innovation that leads to the development of safe and effective products and therapies to patients.
Professionals at all levels involved in the drug discovery, development, and life cycle management of health care products, will travel from China and around the world to share their views, knowledge, experience, and cross-functional content with real-world application.
DIA China Annual Meeting had attracted nearly 1900 attendees in 2015 and will continue to be your essential partner to update knowledge and help to accelerate heath care product development.
Program Committee
-
Jingsong Wang, MD Founder, Chairman, and Chief Executive Officer
Harbour BioMed, China -
Haifeng Cao Regulatory Affairs Director
Boehringer Ingelheim Co. Ltd, China -
Lili Cao, MS Deputy Director
China Center for Food and Drug International Exchange, National Medical Products, China -
Xiaochun Cao
TIGERMED CO.,LTD., China -
George Chen, MD, MBA Senior VP, Global Medicines Development, Head of China Development Unit
AstraZeneca China, China -
Paul Dai, MD Head of Clinical Operations
TDC, Asia, Takeda, China -
Yazhong Deng, MBA CEO and Founder
Beijing Trust Medical Consulting Co. Ltd, China -
Frank Fan, PhD Senior Medical Director
Sanofi, China -
Tony Guo Executive Director, Head of Biometrics China
BeiGene, China -
Min Wang Irwin, MD, PhD Venture Partner
Qiming Weichuang Venture Capital Management (Shanghai) Co. Ltd., China -
Amy Jiang Head of Quality Office
Harbour Biomed, China -
Helen Li, MD, MBA Director, Emerging Market QA Asia Lead
Pfizer Medical, China -
Joy Li Director of pharmacovigilance and medical information
BMS China R&D, China -
Shuting Li, MD Deputy Director
GCP Alliance, China, China -
Vera Liang, MD Sr. Director, Drug Safety Unit Regional Head - APAC
Pfizer (China) R&D Co., Ltd., China -
Jane LIN, MD VP, Strategic Medical Affairs
Johnson & Johnson Medical (China) Ltd., China -
Melly Lin, MS CMC Regulatory Policy Lead, Pharma Technical Regulatory
F. Hoffmann-La Roche Ltd, Switzerland -
Jessica Liu, MD VP, Head of Merges and Acquisition Management Department
Tigermed Consulting Co., Ltd, China -
Roger (Peng) Qu, PhD Head of Clinical Statistics
Pfizer China R&D Center, China -
Hualong Sun General manager
Meta Clinical Technical Co. Ltd, China -
Xiaoling Wang Clinical Documentation
Clinical Science Operation, Sanofi R&D China, China -
Xiuqin Wang, MD Vice Director of Scientific Research Dept.
Jiangsu Province Hospital, China -
Jielai Xia, PhD Director, Department of Medical Statistics
Air Force Military Medical University, China -
Jack Xu, MD, MS Senior Vice President
Shanghai Clinical Research Center (SCRC), China -
Charles Yan Vice President, Head of Clinical Data Science Center
Jiangsu Hengrui, China -
James Yan Executive Vice President, Head of Early Development and Drug Safety,
Zai Lab, China -
Xiaojun (Wendy) Yan, MD, MBA Senior Vice President, Senior Advisor
BeiGene (Beijing) Co., Ltd., China -
Joe Zhang Co-founder and CEO
BJ Bioscience Inc., China -
Mingping Zhang Vice President, Technical
PAREXEL, United States -
Ling Zhen
Quintiles, China -
Xiaoxiang Chen Vice President
Boehringer Ingelheim Shanghai Pharm. Co. Ltd, China -
Carol Zhu, MBA Vice President, Portfolio and Project Management
JW Therapeutics, China -
Janet Lv, MS, RPh Senior Consultant, Roche Pharma Product Development China
Roche , China -
Ling Su, PhD Research Fellow
Shenyang Pharmaceutical University, Yeehong Business School, China -
Ning Xu, MD, MBA Executive Vice President, Head of Global Clinical Operations, Zailab
Zai Lab, China
Have an account?